Literature DB >> 25002586

Susceptibility to HLA-DM protein is determined by a dynamic conformation of major histocompatibility complex class II molecule bound with peptide.

Liusong Yin1, Peter Trenh1, Abigail Guce2, Marek Wieczorek3, Sascha Lange3, Jana Sticht3, Wei Jiang4, Marissa Bylsma2, Elizabeth D Mellins4, Christian Freund3, Lawrence J Stern5.   

Abstract

HLA-DM mediates the exchange of peptides loaded onto MHCII molecules during antigen presentation by a mechanism that remains unclear and controversial. Here, we investigated the sequence and structural determinants of HLA-DM interaction. Peptides interacting nonoptimally in the P1 pocket exhibited low MHCII binding affinity and kinetic instability and were highly susceptible to HLA-DM-mediated peptide exchange. These changes were accompanied by conformational alterations detected by surface plasmon resonance, SDS resistance assay, antibody binding assay, gel filtration, dynamic light scattering, small angle x-ray scattering, and NMR spectroscopy. Surprisingly, all of those changes could be reversed by substitution of the P9 pocket anchor residue. Moreover, MHCII mutations outside the P1 pocket and the HLA-DM interaction site increased HLA-DM susceptibility. These results indicate that a dynamic MHCII conformational determinant rather than P1 pocket occupancy is the key factor determining susceptibility to HLA-DM-mediated peptide exchange and provide a molecular mechanism for HLA-DM to efficiently target unstable MHCII-peptide complexes for editing and exchange those for more stable ones.
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Antigen Presentation; Conformational Change; DM Susceptibility; Enzyme Kinetics; Enzyme Mechanism; Major Histocompatibility Complex (MHC); Protein-Protein Interaction

Mesh:

Substances:

Year:  2014        PMID: 25002586      PMCID: PMC4156084          DOI: 10.1074/jbc.M114.585539

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  71 in total

1.  Indirect recognition of T-cell epitopes derived from the alpha 3 and transmembrane domain of HLA-A2.

Authors:  R Hanvesakul; B Maillere; D Briggs; R Baker; M Larché; S Ball
Journal:  Am J Transplant       Date:  2007-03-12       Impact factor: 8.086

2.  Cutting edge: HLA-DM-mediated peptide exchange functions normally on MHC class II-peptide complexes that have been weakened by elimination of a conserved hydrogen bond.

Authors:  Andrea Ferrante; Jack Gorski
Journal:  J Immunol       Date:  2009-12-28       Impact factor: 5.422

3.  Mediation by HLA-DM of dissociation of peptides from HLA-DR.

Authors:  V S Sloan; P Cameron; G Porter; M Gammon; M Amaya; E Mellins; D M Zaller
Journal:  Nature       Date:  1995-06-29       Impact factor: 49.962

4.  Human monoclonal antibody with T-cell-like specificity recognizes MHC class I self-peptide presented by HLA-DR1 on activated cells.

Authors:  A Wölpl; T Halder; H Kalbacher; H Neumeyer; K Siemoneit; S F Goldmann; T H Eiermann
Journal:  Tissue Antigens       Date:  1998-03

5.  HLA-DM recognizes the flexible conformation of major histocompatibility complex class II.

Authors:  C L Chou; S Sadegh-Nasseri
Journal:  J Exp Med       Date:  2000-12-18       Impact factor: 14.307

6.  Editing of the HLA-DR-peptide repertoire by HLA-DM.

Authors:  H Kropshofer; A B Vogt; G Moldenhauer; J Hammer; J S Blum; G J Hämmerling
Journal:  EMBO J       Date:  1996-11-15       Impact factor: 11.598

7.  FoXS: a web server for rapid computation and fitting of SAXS profiles.

Authors:  Dina Schneidman-Duhovny; Michal Hammel; Andrej Sali
Journal:  Nucleic Acids Res       Date:  2010-05-27       Impact factor: 16.971

8.  HLA-DM captures partially empty HLA-DR molecules for catalyzed removal of peptide.

Authors:  Anne-Kathrin Anders; Melissa J Call; Monika-Sarah E D Schulze; Kevin D Fowler; David A Schubert; Nilufer P Seth; Eric J Sundberg; Kai W Wucherpfennig
Journal:  Nat Immunol       Date:  2010-12-05       Impact factor: 25.606

9.  HLA-DO acts as a substrate mimic to inhibit HLA-DM by a competitive mechanism.

Authors:  Abigail I Guce; Sarah E Mortimer; Taejin Yoon; Corrie A Painter; Wei Jiang; Elizabeth D Mellins; Lawrence J Stern
Journal:  Nat Struct Mol Biol       Date:  2012-12-09       Impact factor: 15.369

Review 10.  HLA-DM Focuses on Conformational Flexibility Around P1 Pocket to Catalyze Peptide Exchange.

Authors:  Liusong Yin; Lawrence J Stern
Journal:  Front Immunol       Date:  2013-10-17       Impact factor: 7.561

View more
  26 in total

1.  Differential scanning fluorimetry based assessments of the thermal and kinetic stability of peptide-MHC complexes.

Authors:  Lance M Hellman; Liusong Yin; Yuan Wang; Sydney J Blevins; Timothy P Riley; Orrin S Belden; Timothy T Spear; Michael I Nishimura; Lawrence J Stern; Brian M Baker
Journal:  J Immunol Methods       Date:  2016-02-18       Impact factor: 2.303

2.  HLA-DO Modulates the Diversity of the MHC-II Self-peptidome.

Authors:  Padma P Nanaware; Mollie M Jurewicz; John D Leszyk; Scott A Shaffer; Lawrence J Stern
Journal:  Mol Cell Proteomics       Date:  2018-12-20       Impact factor: 5.911

3.  Unraveling the structural basis for the unusually rich association of human leukocyte antigen DQ2.5 with class-II-associated invariant chain peptides.

Authors:  Thanh-Binh Nguyen; Priya Jayaraman; Elin Bergseng; M S Madhusudhan; Chu-Young Kim; Ludvig M Sollid
Journal:  J Biol Chem       Date:  2017-03-31       Impact factor: 5.157

Review 4.  The melting pot of the MHC II peptidome.

Authors:  Lawrence J Stern; Laura Santambrogio
Journal:  Curr Opin Immunol       Date:  2016-03-25       Impact factor: 7.486

5.  The Thermodynamic Mechanism of Peptide-MHC Class II Complex Formation Is a Determinant of Susceptibility to HLA-DM.

Authors:  Andrea Ferrante; Megan Templeton; Megan Hoffman; Margaret J Castellini
Journal:  J Immunol       Date:  2015-06-26       Impact factor: 5.422

6.  Evaluating the Role of HLA-DM in MHC Class II-Peptide Association Reactions.

Authors:  Liusong Yin; Zachary J Maben; Aniuska Becerra; Lawrence J Stern
Journal:  J Immunol       Date:  2015-06-10       Impact factor: 5.422

7.  Elevation of c-MYC disrupts HLA class II-mediated immune recognition of human B cell tumors.

Authors:  Jason M God; Christine Cameron; Janette Figueroa; Shereen Amria; Azim Hossain; Bettina Kempkes; Georg W Bornkamm; Robert K Stuart; Janice S Blum; Azizul Haque
Journal:  J Immunol       Date:  2015-01-16       Impact factor: 5.422

Review 8.  Determinants of immunodominance for CD4 T cells.

Authors:  AeRyon Kim; Scheherazade Sadegh-Nasseri
Journal:  Curr Opin Immunol       Date:  2015-01-08       Impact factor: 7.486

Review 9.  What to do with HLA-DO/H-2O two decades later?

Authors:  Robin Welsh; Nianbin Song; Scheherazade Sadegh-Nasseri
Journal:  Immunogenetics       Date:  2019-01-26       Impact factor: 2.846

Review 10.  The love and hate relationship of HLA-DM/DO in the selection of immunodominant epitopes.

Authors:  Robin A Welsh; Scheherazade Sadegh-Nasseri
Journal:  Curr Opin Immunol       Date:  2020-06-28       Impact factor: 7.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.